The vaccine market is booming globally. With the consequent changes in the approach of population, which is focused on preventive healthcare rather than the curative healthcare, the demand for vaccines has increased all over the world. Further, our research reveals that the demand in influenza vaccine market is highly variable and limited numbers of players [...]
As per our research report “Global Vaccine Market Forecast to 2012”, a number of healthcare companies are focusing on cancer vaccine development process to enhance their profit. The cancer vaccine market is expected to grow at a CAGR of 25% during 2009-2012, on the back of government support and increasing participation of private players. We [...]
According to our latest report entitled “Global Vaccine Market Forecast to 2012”, vaccine represents one of the fastest growing segments in healthcare industry. The market for vaccines has been growing at a much faster speed compared to other segments of industry. The splendid growth of the sector has opened a profitable and an effective market [...]
Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The US and Europe represent the two largest vaccine markets in the world and will continue experiencing healthy growth rate in [...]
The worldwide vaccine market has undergone a rapid transformation phase over the last few years. In the present scenario, major pharmaceutical players are eyeing vaccine market for their growth. The global vaccine sales grew at a CAGR of around 28% during 2005-2008, reveals our new research report “Global Vaccine Market Forecast to 2012”. According to [...]
RNCOS has recently added a new Market Research Report titled, “Global Vaccine Market Forecast to 2012” to its report gallery. Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The [...]
The global vaccines market is experiencing a remarkable growth, higher than the growth rate of the traditional pharmaceuticals market. The commercial success of vaccines like Prevnar that generated US$ 2.7 Billion in 2008 has led the pharmaceutical companies to focus on this largely unexplored segment of the pharmaceutical market. Also, with a number of blockbuster [...]
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.